Initiation & Titration of Insulin in Type 2 Diabetes
As type 2 diabetes is characterized by the progressive decline in pancreatic β-cell function, many patients will eventually require insulin to achieve glycemic control. According to the Diabetes Mellitus Status in Canada (DM-SCAN) survey, approximately 60% of those with type 2 diabetes receiving antihyperglycemic therapy were using insulin. Despite this, more than half of the individuals were not meeting the recommended A1C target of ≤7.0%. Pharmacists have the unique opportunity to address the barriers related to insulin and help patients achieve glycemic control.
Developed: January 2016